GSK-SCO104925



A randomized, double-blind placebo-controlled study of treatments with salmeterol, fluticasone propionate and their combination to evaluate novel endpoints in patients with chronic obstructive pulmonary disease
fluticasone propionate/salmeterol
SCO104925
NCT00358358
Pulmonary Disease, Chronic Obstructive
Phase 4
 
An annotated case report form is not available for this study. A blank case report form will be provided.
September 2013